• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

CLOSTRIDIUM DIFFICILE

Role of the Microbiome in Multiple Sclerosis

September 24, 2018Microbiome, Multiple Sclerosis, Nervous System Disorders, Vizit Graphs
Role of the Microbiome in Multiple Sclerosis

Could Multiple Sclerosis be linked to the Microbiome? Use Biovista Vizit, a brainstorming tool for scientists. Explore the live graph.

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

RHEUMATOID ARTHRITIS ANGIOGENESIS REMICADE PSEUDOMONAS AERUGINOSA ALZHEIMER'S DISEASE SOD1 CTLA4 BREAST CANCER RECEPTOR IL23A CELL PROLIFERATION ESCHERICHIA COLI FOXP3 TNF DOXORUBICIN DIABETES MELLITUS CD4 CELL DEATH INSULIN ERBB-2 LISTERIA MONOCYTOGENES 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE TP53 CLOSTRIDIUM DIFFICILE CANDIDA ALBICANS CELL DIVISION HELICOBACTER PYLORI AGING APOPTOTIC PROCESS AUTOPHAGY INFLAMMATION NEURODEGENERATIVE DISORDERS STAPHYLOCOCCUS AUREUS IFNG METFORMIN IMMUNE RESPONSE PORPHYROMONAS GINGIVALIS PARKINSON DISEASE STREPTOCOCCUS PNEUMONIAE IL6 TH17 CELLS IL17A CANCER CELL DIFFERENTIATION CASP3

© 2019 Biovista Vizit All Rights Reserved.